These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1954072)

  • 1. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.
    Oosterhuis B; Jonkman JH; Andersson T; Zuiderwijk PB; Jedema JN
    Br J Clin Pharmacol; 1991 Nov; 32(5):569-72. PubMed ID: 1954072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects.
    Chong E; Kalia V; Willsie S; Winkle P
    J Nephrol; 2014 Dec; 27(6):659-66. PubMed ID: 24699894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.
    Schwartz JI; De Smet M; Larson PJ; Verbesselt R; Ebel DL; Lins R; Lens S; Porras AG; Gertz BJ
    J Clin Pharmacol; 2001 Jan; 41(1):107-12. PubMed ID: 11144988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):481-5. PubMed ID: 8520804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
    Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of gastric pH on the pharmacokinetics of fluconazole: the effect of omeprazole.
    Zimmermann T; Yeates RA; Riedel KD; Lach P; Laufen H
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):491-6. PubMed ID: 7820333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers.
    Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK
    Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.
    Ragueneau I; Poirier JM; Radembino N; Sao AB; Funck-Brentano C; Jaillon P
    Br J Clin Pharmacol; 1999 Sep; 48(3):453-6. PubMed ID: 10510161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide.
    Bækdal TA; Breitschaft A; Navarria A; Hansen CW
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):869-877. PubMed ID: 29897249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects.
    Weber C; Banken L; Birnboeck H; Nave S; Schulz R
    Br J Clin Pharmacol; 1999 Jun; 47(6):701-6. PubMed ID: 10383550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluations of the co-administrations of vandetanib and metformin, digoxin, midazolam, omeprazole or ranitidine.
    Johansson S; Read J; Oliver S; Steinberg M; Li Y; Lisbon E; Mathews D; Leese PT; Martin P
    Clin Pharmacokinet; 2014 Sep; 53(9):837-47. PubMed ID: 25117183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gastric acidity on the bioavailability of digoxin.
    Cohen AF; Kroon R; Schoemaker R; Hoogkamer H; van Vliet A
    Ann Intern Med; 1991 Oct; 115(7):540-5. PubMed ID: 1883123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertension.
    Wermeling DP; Field CJ; Smith DA; Chandler MH; Clifton GD; Boyle DA
    Pharmacotherapy; 1994; 14(5):600-6. PubMed ID: 7997394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.
    Allen A; Vousden M; Lewis A
    Chemotherapy; 1999; 45(6):496-503. PubMed ID: 10567781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No influence of single intravenous doses of omeprazole on theophylline elimination kinetics.
    Oosterhuis B; Jonkman JH; Andersson T; Zuiderwijk PB
    J Clin Pharmacol; 1992 May; 32(5):470-5. PubMed ID: 1587966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of citalopram effect on oral digoxin pharmacokinetics.
    Larsen F; Priskorn M; Overø KF
    J Clin Pharmacol; 2001 Mar; 41(3):340-6. PubMed ID: 11269575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects.
    Soons PA; van den Berg G; Danhof M; van Brummelen P; Jansen JB; Lamers CB; Breimer DD
    Eur J Clin Pharmacol; 1992; 42(3):319-24. PubMed ID: 1577051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.